0001725094-18-000001.txt : 20180110 0001725094-18-000001.hdr.sgml : 20180110 20180110140048 ACCESSION NUMBER: 0001725094-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180110 DATE AS OF CHANGE: 20180110 EFFECTIVENESS DATE: 20180110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kv1.3 Therapeutics, Inc. CENTRAL INDEX KEY: 0001725094 IRS NUMBER: 823583426 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-302850 FILM NUMBER: 18521138 BUSINESS ADDRESS: STREET 1: 219 TERRY AVE. N. STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98092 BUSINESS PHONE: 2063780400 MAIL ADDRESS: STREET 1: 219 TERRY AVE. N. STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98092 D 1 primary_doc.xml X0708 D LIVE 0001725094 Kv1.3 Therapeutics, Inc. 219 TERRY AVE. N. SUITE 300 SEATTLE WA WASHINGTON 98092 2063780400 WASHINGTON None None Corporation true 2017 Craig Philips 219 Terry Ave. N. Suite 300 Seattle WA WASHINGTON 98109-5208 Executive Officer Shawn Iadonato 219 Terry Ave. N. Suite 300 Seattle WA WASHINGTON 98109 Director Lucien Fouke 219 Terry Ave. N. Suite 300 Seattle WA WASHINGTON 98109-5208 Director Robert Hedequist 219 Terry Ave. N. Suite 300 Seattle WA WASHINGTON 98109-5208 Director Gavin Jancke 219 Terry Ave. N. Suite 300 SEATTLE WA WASHINGTON 98109-5208 Director Daniel Raymond 219 Terry Ave. N. Suite 300 Seattle WA WASHINGTON 98109-5208 Director Biotechnology Decline to Disclose 06b false 2018-01-05 false true true false 0 5000000 168182 4831818 false 3 0 0 0 false Kv1.3 Therapeutics, Inc. /S/: Craig W. Philips Craig Philips Interim CEO 2018-01-10